Jeffrey Marrazzo
Directeur/Membre du Conseil chez PRIME MEDICINE, INC.
Fortune : - $ au 31/05/2024
Profil
Jeffrey D.
Marrazzo was the founder and the Chief Executive Officer of Spark Therapeutics, Inc., which was founded in 2013.
He held the position from 2019 to 2022.
Mr. Marrazzo currently holds the position of Director at the Biotechnology Innovation Organization.
He is also a Director at Prime Medicine, Inc. since 2023 and at Chroma Medicine, Inc. since 2022.
In his former positions, Mr. Marrazzo was a Member-Business Development at Tengion, Inc. from 2008 to 2009.
He then served as the Senior Vice President-Business Development at Generation Health, Inc. in 2009.
From 2011 to 2013, he was the Chief Business Officer-US Division at Molecular Health, Inc.Mr. Marrazzo completed his graduate degree at Harvard University.
He also holds an undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRIME MEDICINE, INC.
-.--% | 12/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Jeffrey Marrazzo
| Sociétés | Poste | Début |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur/Membre du Conseil | 10/05/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 04/10/2022 |
Anciens postes connus de Jeffrey Marrazzo
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Fondateur | 01/04/2022 |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2013 |
Generation Health, Inc.
 Generation Health, Inc. Medical/Nursing ServicesHealth Services Generation Health, Inc. provides health management services focuses on genetic testing benefit management. The company was founded by Graham Gardner, J. Christian Kryder, Ricahrad K. Schatzberg, Per G. H. Lofberg, and David M. Margulies on September 23, 2008 and is headquartered in Upper Saddle River, NJ. | Corporate Officer/Principal | 01/01/2009 |
| TENGION, INC. | Corporate Officer/Principal | - |
Formation de Jeffrey Marrazzo
| Harvard University | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TENGION, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Generation Health, Inc.
Generation Health, Inc. Medical/Nursing ServicesHealth Services Generation Health, Inc. provides health management services focuses on genetic testing benefit management. The company was founded by Graham Gardner, J. Christian Kryder, Ricahrad K. Schatzberg, Per G. H. Lofberg, and David M. Margulies on September 23, 2008 and is headquartered in Upper Saddle River, NJ. | Health Services |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
